Author: Staff

Aesculap Biologics achieved 50 percent enrollment in its ongoing phase 3 clinical trial of Novocart 3D, an autologous chondrocyte transplantation system designed to treat articular cartilage defects of the knee.

The global autologous matrix-induced chondrogenesis market is expected to grow at an 8.6 percent compound annual growth rate by 2024, according to a Persistence Market Research report.

Intellijoint Surgical appointed Jonathan M. Vigdorchik, MD, to its scientific advisory board.

Abrazo Medical Group in Arrowhead, Ariz., invested in technology to improve care in Arizona, AZBigMedia reports.

A third-party billing processing vendor inadvertently exposed the personal information of 45,000 Chicago-based Rush University Medical Center patients, The Chicago Tribune reports.

Olympus Medical Systems Group's former president Todd Usen will be the first CEO of Activ Surgical, FierceBiotech reports.

MedShape commercially launched its DynaClip Bone Fixation system.

International Society for the Advancement of Spine Surgery's Reimbursement Task Force Chair Morgan Lorio attended a meeting with CMS to discuss the upcoming Medicare Physician Fee Schedule. Minimally invasive sacroiliac joint fusion was the focus during the meeting.

Pacira acquired Myoscience, a medical device company focused on targeted therapies for pain relief, for up to $220 million.

Hoag Orthopedic Institute in Irvine, Calif., welcomed four orthopedic surgeons and a sports medicine specialist.